Page 4 - Alpha Da News Today

– Treated the first patient with advanced inoperable pancreatic cancer in a safety and feasibility trial in Canada in April –– 89% CR, two-year lo...

Alpha Tau Medical (NASDAQ:DRTS – Get Free Report) released its earnings results on Monday. The company reported ($0.13) EPS for the quarter, meeting the consensus estimate of ($0.13), MarketWatch Earnings reports. Alpha Tau Medical Stock Performance DRTS opened at $3.25 on Tuesday. The firm has a market capitalization of $224.67 million, a PE ratio of […]

– Treated the first patient with advanced inoperable pancreatic cancer in a safety and feasibility trial in Canada in April – – 89% CR, two-year local recurrence-free survival of 77%, and no...

Alpha Tau Medical (NASDAQ:DRTS – Get Free Report) and Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, earnings, institutional ownership, risk, analyst recommendations and valuation. Institutional and Insider Ownership […]

Alpha Tau Medical (NASDAQ:DRTS – Get Free Report) and Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, analyst recommendations, profitability, institutional ownership, dividends and valuation. Risk & Volatility Alpha […]

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Free Report) and Alpha Tau Medical (NASDAQ:DRTS – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, dividends and risk. Risk and Volatility Fresenius […]

- 81 lesions treated across four feasibility trials of head and neck or skin cancers demonstrated 89% complete response rate.

ProSomnus (NASDAQ:OSA – Get Free Report) and Alpha Tau Medical (NASDAQ:DRTS – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, profitability and analyst recommendations. Analyst Recommendations This is a breakdown of […]

Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Free Report) saw a significant decline in short interest in June. As of June 15th, there was short interest totalling 19,700 shares, a decline of 27.6% from the May 31st total of 27,200 shares. Based on an average daily trading volume, of 10,300 shares, the short-interest ratio is currently […]

Alpha Tau Medical Ltd. (NASDAQ:DRTS – Free Report) was the recipient of a significant drop in short interest in June. As of June 15th, there was short interest totalling 91,100 shares, a drop of 52.3% from the May 31st total of 191,000 shares. Based on an average daily volume of 45,400 shares, the days-to-cover ratio […]